REVO Oncology Diagnostics Inc. filed a Form D with the Securities and Exchange Commission on 2026-04-13.
REVO Oncology Diagnostics Inc. filed a Form D notice of an exempt securities offering with the SEC on April 13, 2026. The filing reports $270K sold. Its industry group is Other Health Care. It names Estevan Kiernan (Executive Officer, Director) (SEC Form D, April 13, 2026).
125 companies raised this week.
Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.
| Andersen Aggregator LLC | $1.9B | Business services |
| AT Umbrella LLC | $1.9B | Business services |
| Legora, Inc. | $221M | AI and software |
| MD INVESTMENT LLC | $169M | Business services |
| Serval Inc. | $149M | AI and software |
Is this your company?
Sell to companies like REVO Oncology Diagnostics Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2026-04-13 · the record
Pitching, partnering or investing alongside them? See who really runs and owns REVO Oncology Diagnostics Inc.
Free to see. No signup.
More on the people and the money behind REVO Oncology Diagnostics Inc., from the filings we hold.
Other Health Care raises by companies based in Texas, filed in April 2026, largest first.
Get an email when REVO Oncology Diagnostics Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when REVO Oncology Diagnostics Inc. raises, hires or launches. No email unless you switch it on.
Watch REVO Oncology Diagnostics Inc. →Get the full cited report on REVO Oncology Diagnostics Inc.
What the filing shows about REVO Oncology Diagnostics Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on REVO Oncology Diagnostics Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives REVO Oncology Diagnostics Inc.'s address as 2829 Spanish Moss Trail, Frisco, TX 75033.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on REVO Oncology Diagnostics Inc. See pricing
REVO Oncology Diagnostics Inc. is a registered filer with the SEC (CIK 2114097) and has filed since 2026-04-13. 1 filing is on record, the latest on 2026-04-13.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
REVO Oncology Diagnostics Inc.'s Form D of 2026-04-13 names Estevan Kiernan as its officers, directors or promoters.
Its new offerings report $270K sold across 1 offering, as its own filings state.
Trailing twelve months. 871 filings in Other Health Care, totalled by week. The dot is this raise, $270K, on the same scale — one filing against the whole group's total, so it sits low by construction.
Other than the payment of salaries and other compensation and benefits and reimbursement of expenses, no officer, director, partner, manager or promoter will receive and payments from the proceeds of this Offering.
Estevan Kiernan is named as Executive Officer and Director on the Form D that REVO Oncology Diagnostics Inc. filed with the SEC on 13 April 2026, the only person that filing names.
1 person named on the filing — 1 holding an executive role.
Named as of the 2026-04-13 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
What the filing shows about REVO Oncology Diagnostics Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on REVO Oncology Diagnostics Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on REVO Oncology Diagnostics Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist REVO Oncology Diagnostics Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind REVO Oncology Diagnostics Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for REVO Oncology Diagnostics Inc.. With no account yet, you sign up free and land on the result.
On these lists: Health care raises in Dallas-Fort Worth
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/revo-oncology-diagnostics-inc-form-d-26000001